| http://www.w3.org/ns/prov#value | - wborns and intensive-care patients.Resistance to fluoroquinolones, one of the most widely used antibacterial medicines for the treatment of urinary tract infections caused by E. coli, is also widespread.Resistance was virtually zero when the drugs were introduced in the 1980s, but now hits half of patients in many part of the world, the WHO said.The problem is a particular concern in Africa, the A
|
